Analysts Expect Healthways, Inc. (NASDAQ:TVTY) Will Post Quarterly Sales of $138.21 Million
Brokerages expect that Healthways, Inc. (NASDAQ:TVTY) will report $138.21 million in sales for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Healthways’ earnings, with the lowest sales estimate coming in at $137.35 million and the highest estimate coming in at $138.90 million. Healthways reported sales of $125.05 million during the same quarter last year, which would indicate a positive year over year growth rate of 10.5%. The business is expected to announce its next earnings report on Tuesday, November 7th.
According to Zacks, analysts expect that Healthways will report full-year sales of $138.21 million for the current year, with estimates ranging from $554.58 million to $557.50 million. For the next financial year, analysts anticipate that the firm will report sales of $608.21 million per share, with estimates ranging from $596.95 million to $622.16 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that cover Healthways.
Healthways (NASDAQ:TVTY) last announced its earnings results on Thursday, July 27th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.03. The business had revenue of $138.90 million for the quarter, compared to the consensus estimate of $138.15 million. Healthways had a net margin of 17.30% and a return on equity of 29.81%. Healthways’s quarterly revenue was up 11.1% compared to the same quarter last year.
TVTY has been the subject of several recent analyst reports. ValuEngine upgraded Healthways from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Zacks Investment Research upgraded Healthways from a “hold” rating to a “buy” rating and set a $32.00 price target for the company in a research note on Wednesday, April 26th. Jefferies Group LLC restated a “buy” rating and issued a $36.00 price target (up from $33.00) on shares of Healthways in a research note on Saturday, April 29th. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $41.00 price target (up from $32.00) on shares of Healthways in a research note on Monday, May 1st. Finally, UBS AG upped their price target on Healthways from $37.00 to $43.00 and gave the stock a “buy” rating in a research note on Friday, June 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $38.25.
ILLEGAL ACTIVITY NOTICE: This article was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/13/analysts-expect-healthways-inc-nasdaqtvty-will-post-quarterly-sales-of-138-21-million.html.
Shares of Healthways (TVTY) opened at 36.85 on Friday. The stock has a market capitalization of $1.45 billion, a P/E ratio of 16.60 and a beta of 0.37. Healthways has a 52 week low of $19.25 and a 52 week high of $41.55. The company has a 50-day moving average of $39.29 and a 200-day moving average of $32.55.
In other news, insider Glenn Hargreaves sold 21,105 shares of the company’s stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $38.00, for a total transaction of $801,990.00. Following the sale, the insider now directly owns 59,077 shares of the company’s stock, valued at approximately $2,244,926. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Conan Laughlin sold 1,750,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $37.90, for a total value of $66,325,000.00. The disclosure for this sale can be found here. 8.42% of the stock is owned by corporate insiders.
Several hedge funds have recently modified their holdings of TVTY. Vanguard Group Inc. purchased a new stake in shares of Healthways during the first quarter valued at about $135,544,000. BlackRock Inc. purchased a new stake in shares of Healthways during the first quarter valued at about $123,015,000. Wells Fargo & Company MN purchased a new stake in shares of Healthways during the first quarter valued at about $98,404,000. North Tide Capital LLC purchased a new stake in shares of Healthways during the first quarter valued at about $72,750,000. Finally, Dimensional Fund Advisors LP purchased a new stake in shares of Healthways during the first quarter valued at about $70,660,000.
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.